Online ISSN: 2515-8260

Keywords : PROM

Outcome assessment of total hip arthroplasty patients with limb length discrepancy

Dr. Sarang Shete, Dr. SK Saidapur, Dr. Ravi Jatti, Dr. Kiran Patil

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 2040-2046

THA is a successful orthopaedic intervention & the procedure has relieved pain of many patients, yet some of them remain unsatisfied & has some complications which has least mortality but could have quite reasonable discomfort, especially in initial rehabilitation periods. Difference in the limb length is one among them & this LLD (limb length discrepancy) can persist permanently in these few. Understanding this effect on patients satisfaction is an important aspect.
Thus, in this research we aimed at understanding the outcome of THA patients assessed by using PROM-Patient reported outcome measurement tools like Harris Hip score (HHS) & X- Ray based measurements of change in LLD before & after surgery.
In this prospective study of 6 months follow up of each individual patients of uninfected aetiology & patients above 18 years of age irrespective of gender, we studied 45 hips in total 42 patients. All of them underwent Total Hip Replacement for various reasons of painful end stage arthritis or fractures of hips, with one third young patients having age less than 40 years.
In terms of negative results, only one THA was restored to same LLD from preop to post op (i:e 0 mm to 0 mm-zero to zero) as compared to other 44 Total hips, where change in LLD was observed as inevitable event in a range from 0 to 40 mm LLD in preoperative restored to range of 0 to 20 mm of LLD in the post operative period

A prospective comparation of outcome of labour induction with vaginal misoprostol and intravenous oxytocin in term pre-labour rupture of membranes

Priyadharshini Durairaju, Pritamkumar Singh

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 2100-2104

Aim and Objectives: The aim of the present study was to assess the safety and efficacy of vaginally administered misoprostol 25mg with intravenous oxytocin for labor induction in term prelabour rupture of membranes.
The subjects with rupture of membranes without labor were assigned to receive either vaginally administered misoprostol 25 micrograms or intravenous oxytocin infusion this prospective study was conducted during February 2014 to January 2016 in the Department of Obstetrics and Gynecology of Regional Institute of Medical Sciences, Imphal, India.
Results and Observation: Of the 192 subjects 96 received intravaginal misoprostol and 96 received intravenous oxytocin It was observed that the average interval from start of induction to delivery was about one hour shorter in misoprostol group (12.58+4.08 hours vs 14.00+3.31 hrs) than in oxytocin group (P=0.05). Vaginal delivery occurred in 82 misoprostol treated group and in 80 oxytocin treated group (85.4% vs 83.3%, P= 0.691).Caesarean section was done in 14 of misoprostol treated subjects and in 16 oxytocin treated subjects (14.6% vs 16.7%) which is not statistically significant.
Conclusion: Vaginal administration of misoprostol is an effective alternative to oxytocin infusion for labor induction in women with prelabour rupture of the membranes at term.